Published in Hospital Law Weekly, February 2nd, 2006
Delmarva will have this work performed by its wholly owned subsidiary Health Integrity, LLC.
Health Integrity will monitor the new Medicare prescription drug program for potential fraud, waste or abuse and to investigate any beneficiary complaints related to potential fraud, waste or abuse in the new benefit.
Health Integrity is interested in receiving reports of potential fraud, waste or abuse...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.